Idorsia has a strong and visionary leadership team with the power and drive to create more remarkable innovations and more new medicines.

Board of Directors

Jean-Pierre Garnier

Chairman of the Board

Date of birth: 31 October 1947

Nationality: French and American

Education: MSc in Pharmaceutical Science and PhD in Pharmacology from Louis Pasteur University, Strasbourg, France; MBA from Stanford University, California, US.

Professional background: Various management positions at Schering-Plough. Within SmithKline Beecham, President of the pharmaceutical business in North America (1990), elected to the Board of Directors (1992), Chairman, Pharmaceuticals (from 1994), Chief Operating Officer (COO) (from 1995) and Chief Executive Officer (CEO) (from April 2000). First CEO of GlaxoSmithKline, 2001–2008. CEO of Laboratoires Pierre Fabre, 2008–2010.

Other activities and functions: Member of the Board of Directors of three listed companies, United Technologies Corporation, Renault S.A., Radius Health, Inc., and of one unlisted company, Alzheon, Inc. (Chairman). Operating Partner of the unlisted company Advent International Corporation. Officer de Légion d’Honneur and Knight Commander of the Order of the British Empire.

Jean-Pierre Garnier

Robert J. Bertolini

Date of birth: 19 December 1961

Nationality: American

Education: BA in Economics from Rutgers, the State University of New Jersey, US; Certified Public Accountant licensed in New York and New Jersey, US.

Professional background: Former Executive Vice President and Chief Financial Officer (CFO) of Schering-Plough Corporation; former President and CFO of Bausch & Lomb, Inc. Various executive positions at PricewaterhouseCoopers; former Member of the Board of Directors of Genzyme Corporation.

Other activities and functions: Member of the Board of Directors of two listed companies, Charles River Laboratories International, Inc., and Bristol-Myers Squibb, and of one unlisted company, Physicians World Speakers Bureau.

Robert J. Bertolini

Jean-Paul Clozel

Executive member & CEO

Date of birth: 3 April 1955

Nationality: Swiss and French

Education: Medical degree in France; further training in pharmacology and physiology at the University of Montreal, Canada, and the University of California, San Francisco, US.

Professional background: Practicing cardiologist, 1980–1985. Head of Drug Discovery Group in the Cardiovascular Department of F. Hoffmann-La Roche Ltd, 1985–1997. Founder and CEO of Actelion.

Jean-Paul Clozel

John J. Greisch

Date of birth: 10 June 1955

Nationality: American

Education: Bachelor’s degree in Business Administration from Miami University, Oxford, Ohio, US; Master’s degree in Management (MBA equivalent) from Northwestern University, Illinois, US.

Professional background: CFO, 2004–2006, and President, International Operations, 2006–2009, at Baxter International, Inc.; President and CEO of Hill-Rom Holdings, Inc., since 2010.

Other activities and functions: Member of the Board of AdvaMed, Advanced Medical Technology Association, Washington, D.C., US, and of Ann and Robert Lurie Children’s Hospital, Chicago, US.

John J. Greisch

David Stout

Date of birth: 2 June 1954

Nationality: American

Education: BA in Biology.

Professional background: Held various executive and sales and marketing positions with Schering‑Plough, 1979–1996. Director, US Sales and Marketing, SmithKline Beecham, 1996–1998. President, US Pharmaceuticals, 1999–2003, and President, Pharmaceutical Operations, GlaxoSmithKline, 2003–2008.

Other activities and functions: Member of the Board of Directors of two listed companies, Airgas, Inc. and Jabil, Inc., and of the non-listed company NanoBio Corporation. Member of the Board of Shire plc, from 2010 until 2015.

David Stout

Herna Verhagen

Date of birth: 30 June 1966

Nationality: Dutch

Education: LLM Business Law, University of Nijmegen (1988); MSc Human Resource Studies, University of Tilburg (1991); International Management, Insead (1999); Economics, London School of Economics (2004); MBA, Stanford University (2008).

Professional background: CEO of PostNL N.V. since 2012, having previously served as a member of the Board of Management and held various executive positions within the TNT N.V. Group.

Other activities and functions: Member of the Supervisory Board of Rexel S.A. Member of the Executive Committee and General Board of the Confederation of Netherlands Industry and Employers (VNO-NCW).

Herna Verhagen